Antitumor agent-173

Antitumor agent-173 (Compound 4b) acts as a prodrug of Cycloicaritin and serves as a substrate for OATP2B1. It selectively inhibits the growth of tumor cells and significantly enhances the oral bioavailability of Cycloicaritin. The compound exhibits strong antitumor activity and has a favorable safety profile.

Product Specifications

Field of Research

Cell Biology, Immunology & Inflammation, Protein Biochemistry

Molecular Formula

C28H31NO9

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

MBS1347951-01 0.02 mg (E-Coli)

Recombinant Salmonella typhimurium UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details

MBS1347951-02 0.02 mg (Yeast)

Recombinant Salmonella typhimurium UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details

MBS1347951-03 0.1 mg (E-Coli)

Recombinant Salmonella typhimurium UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details

MBS1347951-04 0.1 mg (Yeast)

Recombinant Salmonella typhimurium UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details

MBS1347951-05 0.02 mg (Baculovirus)

Recombinant Salmonella typhimurium UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details

MBS1347951-06 0.02 mg (Mammalian-Cell)

Recombinant Salmonella typhimurium UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details